Oaktree Capital Management’s Bausch Health BHC Stock Holding History

Oaktree Capital Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,270,000	Closed	-$8.83M	–	148
2025 Q4	$8.83M	Hold	1,270,000	–	–	0.13%	107
2025 Q3	$8.19M	Hold	1,270,000	–	–	0.13%	107
2025 Q2	$8.46M	Hold	1,270,000	–	–	0.15%	79
2025 Q1	$8.22M	Hold	1,270,000	–	–	0.16%	83
2024 Q4	$10.2M	Hold	1,270,000	–	–	0.18%	70
2024 Q3	$10.4M	Hold	1,270,000	–	–	0.17%	71
2024 Q2	$8.85M	Sell	1,270,000 -30,000	-2%	-$227K	0.14%	63
2024 Q1	$13.8M	Hold	1,300,000	–	–	0.22%	46
2023 Q4	$10.4M	Hold	1,300,000	–	–	0.15%	84
2023 Q3	$10.7M	Buy	+1,300,000	New	+$11.2M	0.16%	74

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Oaktree Capital Management's BHC Position: Q1 2026 in Review

Oaktree Capital Management sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 1,270,000 shares — an estimated $8.83M sold.

Oaktree Capital Management first reported a position in BHC in Q3 2023 and held it in 10 quarters. The position peaked at $13.8M in Q1 2024. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

Oaktree Capital Management reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
Oaktree Capital Management sold 1,270,000 Bausch Health shares in Q1 2026, an estimated $8.83M.
Oaktree Capital Management first reported a position in Bausch Health in Q3 2023 and held it in 10 quarters.
Oaktree Capital Management's Bausch Health position peaked at $13.8M in Q1 2024.
228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Oaktree Capital Management's 13F filing for Q1 2026, filed 15 May 2026.